bioMérieux sa SWOT

  • July 2011
  • -
  • MarketLine

examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

BioMerieux is a part of the Institut Merieux group. The industry player is engaged in providing in-vitro diagnostics for medical and industrial applications. The industry player designs, develops, manufactures and industry s systems used in clinical applications, such as for the diagnosis of infectious diseases, and industrial applications, such as for the analysis of industrial or environmental samples. The industry player primarily operates in EMEA (Europe, Middle East and Africa), North America, Asia-Pacific and Latin America. It is headquartered in Marcy l'Etoile, France and employed 6,300 people as of December 2009. The industry player recorded sales of E1,223.4 million (approximately USD 1,706.2 million) during the financial year (FY) ended December 2009, a rise of 10.2% over FY2008. The operating profit of the industry player was E203.7 million (approximately USD 284.1 million) during FY2009, a rise of 9.5% over FY2008. The net profit of the industry player was E147.8 million (approximately USD 206.1 million) in FY2009, a rise of 13.8% over FY2008.

What's Included In This Report?

- Provides all the crucial information on bioMérieux sa required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting bioMérieux sa in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of bioMérieux sa
-Data is supplemented with details on bioMérieux sa history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from bioMérieux sa

Why Should You Buy This Report?

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date industry player information available

Table Of Contents

Table of Contents:

SWOT COMPANY PROFILE: bioMerieux sa
Facts and Figures : bioMerieux sa
Corporate Description : bioMerieux sa
Business Overview : bioMerieux sa
Company History: bioMerieux sa
Top Executives : bioMerieux sa
Resumees : bioMerieux sa
Business Lines (products and services) : bioMerieux sa
Products and Services Analysis: bioMerieux sa
Strategic analysis (SWOT) : bioMerieux sa
*Strengths: bioMerieux sa
*Weaknesses: bioMerieux sa
*Opportunities: bioMerieux sa
*Threats: bioMerieux sa
Company View: bioMerieux sa
Competitive Landscape : bioMerieux sa
Subsidiary : bioMerieux sa
*Head Office: bioMerieux sa
*Other Locations and Subsidiaries: bioMerieux sa

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

Agenus, Inc. - Product Pipeline Review - 2014

Agenus, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Agenus, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Agenus, Inc. - Product Pipeline Review - 2014', provides an overview of the Agenus, Inc.'s pharmaceutical research and ...

Pathology in Germany: MediGene AG – Product Pipeline Review – H2 2011

Pathology in Germany: MediGene AG – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Ambrx, Inc. - Product Pipeline Review - 2014

Ambrx, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Ambrx, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Ambrx, Inc. - Product Pipeline Review - 2014', provides an overview of the Ambrx, Inc.'s pharmaceutical research and development ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.